TrialBMJ (Clinical research ed.)2020

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.

Wei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.